Nearly 2,000 drug manufacturing plants overdue for FDA inspections after COVID delays, AP finds By Matthew Perrone and Nicky Forster - Associated Press Shares
States claim economic harm from abortion pill; case revived after doctors’ legal loss By Alex Swoyer - The Washington Times Shares
Republicans, Democrats push approval of psychedelic treatment for vets, but critics warn of risks By Alex Miller - The Washington Times Shares
FDA approves first nasal spray for severe allergic reactions By Tom Howell Jr. - The Washington Times Shares
Veterans asked for psychedelic therapy, but it may not be enough to save MDMA drug application By Matthew Perrone - Associated Press Shares
Sick of waiting for FDA, U.S. states target food additives banned in Europe By Tom Howell Jr. - The Washington Times Shares
FDA OKs best-selling e-cigarette Vuse Alto, but only in tobacco flavor By Matthew Perrone - Associated Press Shares
FDA OKs first menthol e-cigarettes, citing potential to help adult smokers By Matthew Perrone - Associated Press Shares
Lawmaker says watchdog’s report on FDA handling of infant formula crisis confirms panel’s findings By Kerry Picket - The Washington Times Shares
There’s bird flu in U.S. dairy cows. Raw milk drinkers aren’t deterred By Jonel Aleccia - Associated Press Shares
It’s the first drug shown to slow Alzheimer’s. Why is it off to a slow start? By Tom Murphy - Associated Press Shares
Supreme Court justices weigh rolling back use of the abortion pill By Alex Swoyer - The Washington Times Shares
Biden campaign warns that abortion pill legal case is another impact of Trump agenda By Alex Swoyer - The Washington Times Shares
Mifepristone access is coming before the U.S. Supreme Court. How safe is this abortion pill? By Laura Ungar and Matthew Perrone - Associated Press Shares
Woman suffered complications from abortion pill, now wants Supreme Court to decide its future By Alex Swoyer - The Washington Times Shares
AI chatbots are here to help with your mental health, despite limited evidence they work By Matthew Perrone - Associated Press Shares
New FDA-approved gene therapy for children will cost record $4.25 million By Brad Matthews - The Washington Times Shares